Multicenter study of 9-AC [IDEC 132] in refractory leukemia.
Phase of Trial: Phase I
Latest Information Update: 09 Mar 2011
At a glance
- Drugs IDEC 132 (Primary)
- Indications Acute myeloid leukaemia; Chronic myeloid leukaemia; Precursor cell lymphoblastic leukaemia-lymphoma
- Focus Adverse reactions
- 27 Dec 2007 Status changed from in progress to completed.
- 29 Nov 2005 New trial record.